RecruitingNot ApplicableNCT06909500

A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users

ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation


Sponsor

Fred Hutchinson Cancer Center

Enrollment

1,178 participants

Start Date

Jun 15, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of e-cigarette use by young adults requires effective and accessible treatments to support current users to quit. Research shows this group prefers and benefits from newer methods of treatment delivery such as digital interventions. ACT on Vaping is a digital therapeutic intended to deliver behavioral therapy to young adults who vape to motivate and support abstinence from all nicotine and tobacco products. The app contains sessions that promote awareness of cues that trigger tobacco use and teach skills for responding to these triggers in a way that is tailored for the participant's readiness to quit. Receiving access to the ACT on Vaping app may be effective in helping young adults quit vaping.


Eligibility

Min Age: 18 YearsMax Age: 30 Years

Inclusion Criteria10

  • Age 18-30
  • Current weekly user of e-cigarette product(s) for the last 30 days
  • Has a smartphone; either an Android (running version 12 or higher) or iPhone (running iOS version 17 or higher, iPhone 11 or more recent)
  • Experience downloading and using one or more apps on their smartphone
  • Have a mobile data plan and/or access to WiFi to support the use of the ACT on Vaping app
  • Has access to text messaging
  • Has an email address
  • United States (US) resident, with a US mailing address
  • Willing to complete all study procedures
  • Comfortable reading and writing in English

Exclusion Criteria6

  • Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatment is allowable during trial participation)
  • Member of the same household as another research participant
  • Currently in prison
  • Google voice number as sole phone number, due to its association with fraudulent study entry attempts
  • Is ineligible per fraud prevention protocol
  • Employees/family of investigator or study center

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSmartphone app

Receive access to the ACT on Vaping app

BEHAVIORALSmartphone app

Receive access to the ACT on Vaping app

OTHERText Message

Receive incentivized text messages to access vaping status

OTHERText Message

Receive intervention text messages

OTHERSurvey Administration

Ancillary studies


Locations(1)

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06909500


Related Trials